EKSO - Ekso Bionics Ho Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (1.59%) SPY (0%) DIS (0%) DGAZ (0%) FB (0%) AMD (-0.17%) ALGN (-0.91%) HAL (0%) MSFT (0%) NFLX (0%) NVDA (0%) SNAP (0%) SPCE (0%) V (0%) VXX (0%) WWR (0%) ACB (0.44%) GRPN (0%) GNPX (0%) GILD (0%) FNV (0%) FDX (0%) EL (0%) EEM (0%) DXC (0%)

EKSO - Ekso Bionics Holding...

$0.37 0[0%]

15 mins delayed data

People also watch : IART | LENSF | RVP

+Watchlist

5 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$0.37	Open
Volume		Market Cap	107.04M
Yield		Last Dividend

Day

52 Week

Ekso Bionics collaboration with Kindred ...	02/25/20
Ekso Bionics (NASDAQ:EKSO) is up 20% to $0.45/share after announcing a collaboration with Kindred Healthcare to pilot EksoNR - the most clinically use...

Post Acute Medical (PAM) Accelerates Ado...	02/19/20
ENOLA, Penn. and RICHMOND, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Post Acute Medical, LLC, (PAM), a system of inpatient rehabilitation hospitals, h...

Cantor likes Durect in premarket analyst...	09/06/19
Durect (DRRX) initiated with Overweight rating and $5 (201% upside) price target at Cantor Fitzgerald. Ekso Bionics Holdings (EKSO) initiated with Ove...

The Daily Biotech Pulse: Genmab-Novartis...	08/30/19
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o...

The Daily Biotech Pulse: Mallinkckrodt's...	08/15/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 14) ...

Do Institutions Own Shares In Ekso Bioni...	08/13/19
If you want to know who really controls Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), then you'll have to look at the???

Ekso Bionics and Tonix Pharmaceuticals a...	05/23/19
No summary available.

AVP, PSTG, SSL and SE among midday mover...	05/22/19
No summary available.

Ocular Therapeutix and NewLink Genetics ...	05/22/19
No summary available.

Ekso prices equity offering; shares down...	05/22/19
No summary available.

Ekso details new CCO, groundbreaking cli...	05/06/19
Ekso Bionics (EKSO) has announced the appointment of Bill Shaw as Chief Commercial Officer, with responsibilities of overseeing its global commerciali...

Ekso Bionics (EKSO) Reports Q1 Loss, Lag...	05/01/19
Ekso Bionics (EKSO) delivered earnings and revenue surprises of -25.00% and -9.08%, respectively, for the quarter ended March 2019. Do the numbers hol...

Ekso Bionics Holdings, Inc. (EKSO) CEO J...	05/01/19
No summary available.

Ekso Bionics Holdings misses by $0.02, m...	05/01/19
No summary available.

Ekso down 5% ahead of possible capital r...	04/17/19
No summary available.

Ekso Bionics Holdings, Inc. (EKSO) CEO J...	02/28/19
No summary available.

Ekso Bionics Holdings beats by $0.01, mi...	02/28/19
No summary available.

Ekso Bionics Gets 2 Huge Catalysts With ...	02/12/19
Ekso Bionics shares jumped on news of a joint venture in China. China offers a huge opportunity with a large and growing population of stroke patients...

Co-Diagnostics leads healthcare gainers;...	01/30/19
No summary available.

Ekso Bionics up 35% on announcing JV in ...	01/30/19
No summary available.

Ekso Bionics down 6% premarket on prelim...	01/08/19
No summary available.

ANALYST RATINGS

2 analyst ratings (Last 6 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	10/28/19
H.C. Wainwright initiates coverage with Buy rating and announces Price Target of $1.20

Strong Buy rating	09/06/19
Cantor Fitzgerald initiates coverage with Overweight rating and announces Price Target of $1.00

EARNINGS

Date	Today (AMC)	Est. (EPS/Rev.)	($0.04)/ 3.65M
Actual (EPS/Rev.)	/	EPS (TTM)	0

TRADERS TRACKING $EKSO

Service Name	Trader	% Success
Technical Swing Picks	Kaffel	60.00 %	Follow
R R Investments	Roland Van Rij	19.00 %	Follow
Small Cap Trader	James Bills	18.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.